Drug
CS 3150
CS 3150: highest development phase Phase 2, developed by Daiichi Sankyo. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Daiichi Sankyo
Trials
| Drug | Phase | Indication |
|---|---|---|
| CS-3150 NCT02448628 | Phase 2 | Hypertension |
Latest
No recent events.
Follow CS 3150 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.